Bill > LB762

This bill mandates that starting January 1, 2027, individual and group sickness and accident insurance policies, subscriber contracts, and hospital, medical, or surgical expense-incurred policies (excluding limited benefit coverage) delivered, issued, or renewed in Nebraska must cover treatments for two specific pediatric autoimmune disorders: pediatric autoimmune neuropsychiatric disorder associated with a Group A streptococcal infection and pediatric acute-onset neuropsychiatric syndrome. This requirement also extends to self-funded employee benefit plans to the extent permitted by federal law. The bill defines pediatric acute-onset neuropsychiatric syndrome as a sudden onset of obsessive-compulsive or tic disorders, or other behavioral changes in children and adolescents not explained by other known medical conditions, and pediatric autoimmune neuropsychiatric disorder associated with a Group A streptococcal infection as a condition where a strep infection in a child or adolescent triggers the sudden appearance or worsening of neuropsychiatric symptoms. Treatments covered must be recommended by the patient's physician and can include antibiotics, medications and behavioral therapies for symptom management, plasma exchange, and immunoglobulin.